SPLICE VARIANT SPECIFIC MESSENGER RNA TRANSCRIPTS AS BIOMARKERS OF PARKINSON'S DISEASE

• 1. 取代的吡咯衍生物、含这些衍生物的药用组合物以及用其治疗帕金森氏病的方法 [P] . 中国专利： CN102333764B . 2016.01.06
• 2. 取代的吡咯衍生物、含这些衍生物的药用组合物以及用其治疗帕金森氏病的方法 [P] . 中国专利： CN102333764A . 2012-01-25
• 3. Splice variant specific messenger RNA transcripts as biomarkers of parkinson's disease [P] . 美国专利： US8772468B2 . 2014-07-08

  机译： 剪接变体特异的信使RNA转录本作为帕金森氏病的生物标记

• 4. Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases [P] . 美国专利： US2007087376A1 . 2007-04-19

  机译： 前mRNA转录的剪接变体作为特发性神经退行性疾病的生物标志物

• 5. ALTERNATIVELY SPLICED PRE-MRNA TRANSCRIPTS AS BIOMARKERS IN IDIOPATHIC NEURODEGENERATIVE DISEASES [P] . 世界知识产权组织专利： WO2008127317A3 . 2009-02-12

  机译： 选择性剪接的pre-mRNA转录作为特发性神经退行性疾病中的生物标志物

• 1. Need for multiple biomarkers to adjust parameters of closed-loop deep brain stimulation for Parkinson's disease [J] . Takashi Morishita, Tooru Inoue 中国神经再生研究（英文版） . 2017,第005期
• 2. microRNAs regulation and its role as biomarkers in diseases [J] . Huandi Zhou, Xiaohui Ge, Xiaoying Xue 肿瘤学与转化医学（英文） . 2016,第001期
• 3. microRNAs regulation and its role as biomarkers in diseases [J] . Huandi Zhou, Xiaohui Ge, Xiaoying Xue 中德临床肿瘤学杂志（英文版） . 2016,第001期
• 4. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression [J] . McLean J.R., Hallett P.J., Cooper O., Molecular and cellular neurosciences . 2012,第2期
• 5. Imaging of endogenous messenger RNA splice variants in living cells reveals nuclear retention of transcripts inaccessible to nonsense-mediated decay in Arabidopsis. [J] . Gohring J., Jacak J., Barta A. The Plant Cell . 2014,第2期
• 6. Splice variant-specific silencing of angiotensin II type 1a receptor messenger RNA by RNA interference in vascular smooth muscle cells. [J] . Hassan A, Ji H, Zhang Y, Biochemical and Biophysical Research Communications . 2006,第2期
• 7. Widespread predicted nonsense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes [C] . Richard E. Green, Benjamin P. Lewis, R. Tyler Hillman, International Conference on Intelligent Systems for Molecular biology . 2003
• 8. HyPR-MS for Multiplexed and Splice Variant-Specific Discovery of RNA-Protein Interactomes [D] . Knoener, Rachel A. 2017
• 9. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson’s disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression [O] . Jesse R. McLean, Penelope J. Hallett, Oliver Cooper, -1
• 10. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression [O] . Jesse R. McLean, Penelope J. Hallett, Oliver Cooper, 2012
• 11. Splice Variant Biomarkers for Parkinson's Disease. [R] . Potashkin, J. 2014

• 1. Alternative RNA splicing in stem cells and cancer stem cells:Importance of transcript-based expression analysis [J] . Esmaeil Ebrahimie ,Samira Rahimirad ,Mohammadreza Tahsili . 世界干细胞杂志:英文版(电子版) . 2021,第10期
• 2. Three new alternative splicing variants of human cytochrome P450 2D6 mRNA in human extratumoral liver tissue [J] . JianZhuge Ying-NianYu . 世界胃肠病学杂志：英文版 . 2004,第22期
• 3. 应用唇腺α-突触核蛋白诊断帕金森病的生物学标记物研究 [C] . 郜丽妍 ,冯涛 . 2015北京医学会神经病学学术年会 . 2015
• 4. 正电子显像剂11C-Fethypride化学合成、放射性标记及在帕金森氏病的应用 [A] . 林秋玉 . 2021